{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coronavirus", "Envelope protein", "Indian medicinal plants", "Inhibitors", "Molecular docking", "SARS-CoV-2 E"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35403092", "DateRevised": {"Year": "2023", "Month": "02", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1016/j.phyplu.2022.100241"], "Journal": {"ISSN": "2667-0313", "JournalIssue": {"Volume": "2", "Issue": "2", "PubDate": {"Year": "2022", "Month": "May"}}, "Title": "Phytomedicine plus : international journal of phytotherapy and phytopharmacology", "ISOAbbreviation": "Phytomed Plus"}, "ArticleTitle": "Molecular and structural insights of \u03b2-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors.", "Pagination": {"StartPage": "100241", "MedlinePgn": "100241"}, "Abstract": {"AbstractText": ["Over million people have been infected with SARS-CoV-2 virus worldwide, with around 3% reported deaths till date. A few conventional antiviral treatments have been tried to mitigate the coronavirus. However, many alternative therapeutics are being evaluated worldwide. In the present study, we investigated traditional Indian medicinal compounds antiviral potencies as an effective drug for targeting SARS-CoV-2E. SARS-CoV-2 E protein plays a key role in coronavirus life cycle and is an interesting target for the development of anti-SARS-CoV-2 E drugs.", "Molecular docking studies of medicinal compounds possessing wide range of pharmacological and antiviral activities against enveloped viruses were evaluated with the computer-aided drug design screening software; PyRx. Twelve medicinal compounds isolated from plants were screened and visualized on Biovia Discovery-Studio. Moreover, SARS-CoV-2 E protein's secondary structural insights were deciphered using Swiss Model and ProFunc web server.", "Glycyrrhizic acid, triterpene glycoside isolated from plants of\u00a0<i>Glycyrrhiza</i> (licorice) showed interactions with envelope protein at chain A: Arg 61, chain B: Phe 23, chain B: Tyr 57, and chain C: Val 25. \u03b2- boswellic acid, an ayurvedic herb (pentacyclic terpenoid are produced by <i>Boswellia</i>) represented direct interactions and indirect binding with chain C. Their pharmacological aspects and drug-likeness properties were deduced by DruLiTo. Toxicological assessment, along with their ADME profiling, was validated using vNNADMET. The findings showed that ligands, \u03b2-boswellic acid, and glycyrrhizic acid possessed the best bindings, with the target having binding affinity (-9.1\u00a0kcal/mol) amongst compounds tested against SARS-CoV-2 E. <i>In-vitro</i> studies reveals the promising effect as potent SARS-CoV-2 E inhibitors. Functionality loss and structural disruptions with \u223c90% were observed by UV-spectra and fluorescent based analyses.", "The study demonstrated that \u03b2-boswellic acid, and glycyrrhizic acid are strong SARS-CoV-2 E protein inhibitors. In addition, the work linked GA antiviral activity to its effect on SARS-CoV- 2 E protein that can pave the way for designing antiviral therapeutics."], "CopyrightInformation": "\u00a9 2022 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Enzyme and Microbial Biochemistry Laboratory,Department of Chemistry,Indian Institute of Technology Delhi, New Delhi 110016, India."}], "LastName": "Fatima", "ForeName": "Syeda Warisul", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Enzyme and Microbial Biochemistry Laboratory,Department of Chemistry,Indian Institute of Technology Delhi, New Delhi 110016, India."}], "LastName": "Alam", "ForeName": "Shahenvaz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Enzyme and Microbial Biochemistry Laboratory,Department of Chemistry,Indian Institute of Technology Delhi, New Delhi 110016, India."}], "LastName": "Khare", "ForeName": "Sunil K", "Initials": "SK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Phytomed Plus", "NlmUniqueID": "9918382982506676", "ISSNLinking": "2667-0313"}, "CoiStatement": "The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmad S., Zahiruddin S., Parveen B., Basist P., Parveen A., Parveen R., Ahmad M. Indian medicinal plants and formulations and their potential against COVID-19\u2013preclinical and clinical research. Front. Pharmacol. 2021;11:2470. 10.3389/fphar.2020.578970.", "ArticleIdList": ["PMC7962606", "33737875"]}, {"Citation": "Alam S., Fatima S.W., Khare S.K. Unravelling promise of Indian herbal compounds as potential COVID-19 therapeutic agent. Res. Sq. 2020;1:1\u201315. 10.21203/rs.3.rs-41688/v1."}, {"Citation": "Benarba B., Pandiella A. Medicinal plants as sources of active molecules against COVID-19. Front. Pharmacol. 2020;11:1189. 10.3389/fphar.2020.01189.", "ArticleIdList": ["PMC7427466", "32848790"]}, {"Citation": "BIOVIA . Dassault Syst\u00e8mes; San Diego: 2020. Dassault Syst\u00e8mes, BIOVIA Workbook, Release 2020; BIOVIA Pipeline Pilot, Release."}, {"Citation": "Bojadzic D., Alcazar O., Buchwald P. Methylene blue inhibits the SARS-CoV-2 spike\u2013ACE2 protein-protein interaction\u2013a mechanism that can contribute to its antiviral activity against COVID-19. Front. Pharmacol. 2020;11:2255. 10.3389/fphar.2020.600372.", "ArticleIdList": ["PMC7838506", "33519460"]}, {"Citation": "Caliebe R.H., Scior T., Ammon H.P. Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: bioinformatic studies. Arch. Pharm. 2021;354 e2100160. 10.1002/ardp.202100160.", "ArticleIdList": ["PMC8646807", "34427335"]}, {"Citation": "Collins F. Bringing needed structure to COVID-19 drug development. USA: National Institutes of Health. 2020 https://directorsblog.nih.gov/2020/04/02/bringing-needed-structure-to-covid-19-drug-development/. Accessed 16 December 2021."}, {"Citation": "Dallakyan S., Olson A.J. Small-Molecule library screening by docking with PyRx. Chem. Biol. Humana Press, New York. 2015:243\u2013250.", "ArticleIdList": ["25618350"]}, {"Citation": "Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. British Med. J. 2020;368:1086. 10.1136/bmj.m1086.", "ArticleIdList": ["32184201"]}, {"Citation": "Gomaa A.A., Mohamed H.S., Abd-Ellatief R.B., Gomaa M.A. Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology. 2021;29:1033\u20131048. doi: 10.1007/s10787-021-00841-8.", "ArticleIdList": ["10.1007/s10787-021-00841-8", "PMC8256410", "34224069"]}, {"Citation": "Javorsky A., Humbert P.O., Kvansakul M. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain. Commun. Biol. 2021;4:1\u20138. 10.1038/s42003-021-02250-7.", "ArticleIdList": ["PMC8196010", "34117354"]}, {"Citation": "Khan S.A., Al-Balushi K. Combating COVID-19: the role of drug repurposing and medicinal plants. J. Infect. Public Health. 2021;14:495\u2013503. 10.1016/j.jiph.2020.10.012.", "ArticleIdList": ["PMC7590838", "33743371"]}, {"Citation": "Li J., Xu D., Wang L., Zhang M., Zhang G., Li E., He S. Glycyrrhizic acid inhibits SARS-CoV-2 infection by blocking spike protein-mediated cell attachment. Molecules. 2021;26:6090. 10.3390/molecules26206090.", "ArticleIdList": ["PMC8539771", "34684671"]}, {"Citation": "Mandala V.S., McKay M.J., Shcherbakov A.A., Dregni A.J., Kolocouris A., Hong M. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat. Struct. Mol. Biol. 2020;27:1202\u20131208. 10.1038/s41594-020-00536-8.", "ArticleIdList": ["PMC7718435", "33177698"]}, {"Citation": "Mousavizadeh L., Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J. Microbiol. Immunol. Infect. 2021;54:159\u2013163. 10.1016/j.jmii.2020.03.022.", "ArticleIdList": ["PMC7138183", "32265180"]}, {"Citation": "Patel B., Sharma S., Nair N., Majeed J., Goyal R.K., Dhobi M. Therapeutic opportunities of edible antiviral plants for COVID-19. Mol. Cell Biochem. 2021;476:2345\u20132364. 10.1007/s11010-021-04084-7.", "ArticleIdList": ["PMC7882868", "33587232"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605\u20131612. 10.1002/jcc.20084.", "ArticleIdList": ["15264254"]}, {"Citation": "Roy A., Menon T. Evaluation of bioactive compounds from Boswellia serrata against SARS CoV 2. Vegetos. 2021;17:1\u201311. 10.1007/s42535-021-00318-7.", "ArticleIdList": ["PMC8595075", "34803247"]}, {"Citation": "Saravanan K.M., Zhang H., Senthil R., Kumar Vijayakumar K., Sounderrajan V., Wei Y., Shakila H. Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds. J. Biomol. Struct. Dyn. 2020 10.1080/07391102.2020.183445.", "ArticleIdList": ["PMC7594188", "33073712"]}, {"Citation": "Sarkar M., Saha S. Structural insight into the role of novel SARS-CoV-2 E protein: a potential target for vaccine development and other therapeutic strategies. PLoS ONE. 2020;15 10.1371/journal.pone.0237300.", "ArticleIdList": ["PMC7423102", "32785274"]}, {"Citation": "Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56 10.1016%2Fj.ijantimicag.2020.106054.", "ArticleIdList": ["PMC7286265", "32534188"]}, {"Citation": "Sun Z., He G., Huang N., Thilakavathy K., Lim J.C.W., Kumar S.S., Xiong C. Glycyrrhizic acid: a natural plant ingredient as a drug candidate to treat COVID-19. Front. Pharmacol. 2021;12:1740. 10.3389/fphar.2021.707205.", "ArticleIdList": ["PMC8298820", "34305613"]}, {"Citation": "Surya W., Li Y., Torres J. Structural model of the SARS coronavirus E channel in LMPG micelles. Biochim. Biophys. Acta Biomembr. 2018;1860:1309\u20131317. 10.1016/j.bbamem.2018.02.017.", "ArticleIdList": ["PMC7094280", "29474890"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461. 10.1002/jcc.21334.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "van de Sand L., Bormann M., Alt M., Schipper L., Heilingloh C.S., Steinmann E., Todt D., Dittmer U., Elsner C., Witzke O., Krawczyk A. Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease. Viruses. 2021;13:609. 10.3390/v13040609.", "ArticleIdList": ["PMC8066091", "33918301"]}, {"Citation": "Verma A.K., Kumar V., Singh S., Goswami B.C., Camps I., Sekar A., Yoon S., Lee K.W. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies. Biomed. Pharmacother. 2021;137 10.1016/j.biopha.2021.111356.", "ArticleIdList": ["PMC7857054", "33561649"]}, {"Citation": "Westerbeck J.W., Machamer C.E. The infectious bronchitis coronavirus envelope protein alters Golgi pH to protect the spike protein and promote the release of infectious virus. J. Virol. 2019;93:15\u201319. 10.1128/JVI.00015-19.", "ArticleIdList": ["PMC6532078", "30867314"]}, {"Citation": "World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID 19-11 March 2020."}, {"Citation": "Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J., Sheng J. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325\u2013328. 10.1016/j.chom.2020.02.001.", "ArticleIdList": ["PMC7154514", "32035028"]}, {"Citation": "Wu J., Chiwaya N. Coronavirus map: the COVID-19 virus is spreading across the world. Here\u2019s where cases have been confirmed. USA: NBC News. 2020 https://www.nbcnews.com/health/health-news/coronavirus-map-confirmed-cases-2020-n1120686. Accessed 8 January 2022."}, {"Citation": "Yu S., Zhu Y., Xu J., Yao G., Zhang P., Wang M., Zhao Y., Lin G., Chen H., Chen L., Zhang J. Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2. Phytomedicine. 2021;85 10.1016/j.phymed.2020.153364.", "ArticleIdList": ["PMC7531286", "33041173"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "11", "Hour": "5", "Minute": "34"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35403092", "PMC8840829", "10.1016/j.phyplu.2022.100241", "S2667-0313(22)00027-6"]}}], "PubmedBookArticle": []}